Is a complete GDTC research report available?

No complete published report is available for CytoMed Therapeutics Limited (GDTC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CytoMed Therapeutics Limited (GDTC)

NASDAQ: GDTC · USD

$0.91

+0.00 (+0.0%)· Recorded snapshot

Market cap	10.9M
Revenue (ttm)	609.7K
Net income (ttm)	-2.7M
EPS (ttm)	-$0.23
Shares out	11.9M
Volume	5,178
Beta	0.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 609.7K
Net income (ttm): -2.7M
EPS (ttm): -$0.23
Market cap: 10.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001873093
Company name	CytoMed Therapeutics Limited
Country	Singapore
Country code	US
Employees	42
Employees change	-1
Employees growth	-2.33%
Enterprise value	$10.1M
Exchange	NASDAQ
Financial currency	SGD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Biotechnology
IPO date	2023-04-14
Is primary listing	Yes
Is SPAC	No
ISIN number	SGXZ17669631
Last 10-K release date	2026-03-31
Last earnings date	2026-04-24
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$10.9M
Market cap category	Nano-Cap
Next earnings date	2026-05-01
Options	No
Price	$0.91
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	GDTC
Website	https://w2.cytomed.sg

Metric

Value

Amount currency

USD

CIK code

0001873093

Company name

CytoMed Therapeutics Limited

Country

Singapore

Country code

Employees

Employees change

-1

Employees growth

-2.33%

Enterprise value

$10.1M

Exchange

NASDAQ

Financial currency

SGD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

Industry

Biotechnology

IPO date

2023-04-14

Is primary listing

Yes

Is SPAC

ISIN number

SGXZ17669631

Last 10-K release date

2026-03-31

Last earnings date

2026-04-24

Last refreshed

2026-11-04

Last stock split type

Never

Market cap

$10.9M

Market cap category

Nano-Cap

Next earnings date

2026-05-01

Options

Price

$0.91

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-11-03

Symbol

GDTC

Website

https://w2.cytomed.sg

Metric	Value
Earnings yield	-25.2%
EV/Sales	16.54x
FCF / EV yield	-32.75%
FCF yield	-30.41%
P/B ratio	2.83x
P/S ratio	17.81x
Price / tangible book value	2.89x
Sector forward P/E	23.49x
Sector P/E	49.21x

Metric

Value

Earnings yield

-25.2%

EV/Sales

16.54x

FCF / EV yield

-32.75%

FCF yield

-30.41%

P/B ratio

2.83x

P/S ratio

17.81x

Price / tangible book value

2.89x

Sector forward P/E

23.49x

Sector P/E

49.21x

Metric	Value
Gross margin	85.89%
Operating margin	-506.84%
Pretax margin	-449.24%
Profit per employee	$-64,527
Revenue per employee	$14,517
ROA	-32.52%
ROA (5Y)	-23.32%
ROCE	-69.06%
ROE	-56.17%
ROE (5Y)	-95.18%
ROIC	-36.85%
SBC / revenue	33.05%

Metric

Value

Gross margin

85.89%

Operating margin

-506.84%

Pretax margin

-449.24%

Profit per employee

$-64,527

Revenue per employee

$14,517

ROA

-32.52%

ROA (5Y)

-23.32%

ROCE

-69.06%

ROE

-56.17%

ROE (5Y)

-95.18%

ROIC

-36.85%

SBC / revenue

33.05%

Metric	Value
EPS growth years	0
Gross profit growth	0.37%
Gross profit growth (Q)	49.37%
Gross profit growth 3Y	6.41%
Gross profit growth 5Y	50.39%
Net income growth years	0
Revenue growth	8.11%
Revenue growth (Q)	-15.93%
Revenue growth (QoQ)	-7.63%
Revenue growth 3Y	11.22%
Revenue growth 5Y	55.04%
Revenue growth years	1

Metric

Value

EPS growth years

Gross profit growth

0.37%

Gross profit growth (Q)

49.37%

Gross profit growth 3Y

6.41%

Gross profit growth 5Y

50.39%

Net income growth years

Revenue growth

8.11%

Revenue growth (Q)

-15.93%

Revenue growth (QoQ)

-7.63%

Revenue growth 3Y

11.22%

Revenue growth 5Y

55.04%

Revenue growth years

Metric	Value
Capital expenditures	$-372,863
Depreciation and amortization	$345,025
EBIT	$-3.1M
EBITDA	$-2.7M
EPS	$-0.23
FCF per share	$-0.28
Financing cash flow	$932,842
Free cash flow	$-3.3M
Free cash flow minus SBC	$-3.5M
Gross profit	$523,720
Investing cash flow	$770,377
Net borrowing	$735,197
Net cash flow	$-1.1M
Net income	$-2.7M
Operating cash flow minus SBC	$-3.1M
Operating income	$-3.1M
Revenue	$609,727
Stock-based compensation	$201,538

Metric

Value

Capital expenditures

$-372,863

Depreciation and amortization

$345,025

EBIT

$-3.1M

EBITDA

$-2.7M

EPS

$-0.23

FCF per share

$-0.28

Financing cash flow

$932,842

Free cash flow

$-3.3M

Free cash flow minus SBC

$-3.5M

Gross profit

$523,720

Investing cash flow

$770,377

Net borrowing

$735,197

Net cash flow

$-1.1M

Net income

$-2.7M

Operating cash flow minus SBC

$-3.1M

Operating income

$-3.1M

Revenue

$609,727

Stock-based compensation

$201,538

Metric	Value
Altman Z-Score	2.81
Book value per share	$0.32
Debt / equity	0.08
Goodwill	$278
Interest coverage	-192.87
Long-term assets	$2.9M
Long-term liabilities	$290,772
Net cash (debt)	$776,322
Net cash / market cap	7.15%
Net cash growth	-84.29%
Net debt / equity	-0.19
Piotroski F-Score	2
Property, plant and equipment	$2.9M
Shareholders' equity	$4.2M
Tangible book value	$3.8M
Tangible book value per share	$0.32
Total assets	$5.4M
Total cash	$1.1M
Total debt	$350,929
Total liabilities	$1.2M
WACC	4.61%

Metric

Value

Altman Z-Score

2.81

Book value per share

$0.32

Debt / equity

0.08

Goodwill

$278

Interest coverage

-192.87

Long-term assets

$2.9M

Long-term liabilities

$290,772

Net cash (debt)

$776,322

Net cash / market cap

7.15%

Net cash growth

-84.29%

Net debt / equity

-0.19

Piotroski F-Score

Property, plant and equipment

$2.9M

Shareholders' equity

$4.2M

Tangible book value

$3.8M

Tangible book value per share

$0.32

Total assets

$5.4M

Total cash

$1.1M

Total debt

$350,929

Total liabilities

$1.2M

WACC

4.61%

Metric	Value
Asset turnover	0.1
Current assets	$2.5M
Current liabilities	$957,809
Current ratio	2.64
Inventory turnover	0.12
Net working capital	$475,760
Quick ratio	1.51
Working capital	$1.6M
Working capital turnover	0.13

Metric

Value

Asset turnover

0.1

Current assets

$2.5M

Current liabilities

$957,809

Current ratio

2.64

Inventory turnover

0.12

Net working capital

$475,760

Quick ratio

1.51

Working capital

$1.6M

Working capital turnover

0.13

Metric	Value
Buyback yield / dilution	-2.4%
Dividend yield	0%
Shareholder yield	-2.4%

Metric

Value

Buyback yield / dilution

-2.4%

Dividend yield

Shareholder yield

-2.4%

Metric	Value
150-day SMA	$0.97
1D price change	0.02%
1M price change	-1.09%
1M total return	-1.09%
1W price change	2.25%
1W total return	2.25%
1Y price change	-58.64%
1Y return CAGR	-58.66%
1Y total return	-58.64%
20-day SMA	$0.90
200-day SMA	$0.98
3M price change	-2.16%
3M total return	-2.16%
3Y price change	-76.61%
3Y return CAGR	-38.38%
3Y total return	-76.61%
50-day SMA	$0.90
50-day SMA vs 200-day SMA	50under200
52-week high	$3.10
52-week high date	2025-11-06
52-week low	$0.68
52-week low date	2026-05-08
6M price change	-6.52%
6M total return	-6.52%
All-time high	$9.25
All-time high date	2023-07-11
All-time low	$0.68
All-time low date	2026-05-08
Average true range (ATR)	$0.10
Average volume	15.7K
Beta (1Y)	-0.37
Beta (2Y)	-0.02
Beta (5Y)	0.07
Change from 52-week high	-70.65%
Change from 52-week low	33.8%
Change from all-time high	-90.16%
Change from all-time low	33.8%
Change from open	-1.09%
Day's gap	1.12%
Dollar volume	$4,712
High price	$0.92
Low price	$0.85
Monthly RSI	38.4
Open price	$0.92
Position in 52-week range	85.29%
Previous close	$0.91
Price vs 150-day SMA	-5.89%
Price vs 20-day SMA	1.25%
Price vs 200-day SMA	-6.94%
Price vs 50-day SMA	0.67%
Relative volume	0.33
Return from IPO open	-77.25%
Return from IPO price	-77.25%
RSI	50.79
Sharpe ratio	-0.63
Sharpe ratio (3Y)	-0.12
Sortino ratio	-0.87
Sortino ratio (3Y)	-0.11
Volume	5.2K
Weekly RSI	44.96
YTD price change	-31.84%
YTD total return	-31.84%

Metric

Value

150-day SMA

$0.97

1D price change

0.02%

1M price change

-1.09%

1M total return

-1.09%

1W price change

2.25%

1W total return

2.25%

1Y price change

-58.64%

1Y return CAGR

-58.66%

1Y total return

-58.64%

20-day SMA

$0.90

200-day SMA

$0.98

3M price change

-2.16%

3M total return

-2.16%

3Y price change

-76.61%

3Y return CAGR

-38.38%

3Y total return

-76.61%

50-day SMA

$0.90

50-day SMA vs 200-day SMA

50under200

52-week high

$3.10

52-week high date

2025-11-06

52-week low

$0.68

52-week low date

2026-05-08

6M price change

-6.52%

6M total return

-6.52%

All-time high

$9.25

All-time high date

2023-07-11

All-time low

$0.68

All-time low date

2026-05-08

Average true range (ATR)

$0.10

Average volume

15.7K

Beta (1Y)

-0.37

Beta (2Y)

-0.02

Beta (5Y)

0.07

Change from 52-week high

-70.65%

Change from 52-week low

33.8%

Change from all-time high

-90.16%

Change from all-time low

33.8%

Change from open

-1.09%

Day's gap

1.12%

Dollar volume

$4,712

High price

$0.92

Low price

$0.85

Monthly RSI

38.4

Open price

$0.92

Position in 52-week range

85.29%

Previous close

$0.91

Price vs 150-day SMA

-5.89%

Price vs 20-day SMA

1.25%

Price vs 200-day SMA

-6.94%

Price vs 50-day SMA

0.67%

Relative volume

0.33

Return from IPO open

-77.25%

Return from IPO price

-77.25%

RSI

50.79

Sharpe ratio

-0.63

Sharpe ratio (3Y)

-0.12

Sortino ratio

-0.87

Sortino ratio (3Y)

-0.11

Volume

5.2K

Weekly RSI

44.96

YTD price change

-31.84%

YTD total return

-31.84%

Metric	Value
Float	3.5M
Float percentage	29.51%
Shares change (QoQ)	1.07%
Shares change (YoY)	2.4%
Shares held by insiders	21.51%
Shares held by institutions	0.14%
Shares outstanding	11.9M
Short % of float	0.55%
Short % of shares	0.16%
Short ratio	0.9 days

Metric

Value

Float

3.5M

Float percentage

29.51%

Shares change (QoQ)

1.07%

Shares change (YoY)

2.4%

Shares held by insiders

21.51%

Shares held by institutions

0.14%

Shares outstanding

11.9M

Short % of float

0.55%

Short % of shares

0.16%

Short ratio

0.9 days

CytoMed Therapeutics Limited (GDTC)

Price

Financial snapshot

Fair-value bridge

Latest news · GDTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GDTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GDTC

Frequently asked questions